4//SEC Filing
Lafond Kevin G 4
Accession 0001209191-21-003244
CIK 0001107421other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:34 PM ET
Size
5.0 KB
Accession
0001209191-21-003244
Insider Transaction Report
Form 4
Lafond Kevin G
Vice Pres., Treasurer, & CAO
Transactions
- Sale
Common Stock
2021-01-08$3.09/sh−18,020$55,682→ 63,965 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001429559
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 4:34 PM ET
- Size
- 5.0 KB